Skip to main content
Clinical Trials/ACTRN12624000896572
ACTRN12624000896572
Not Yet Recruiting
N/A

Fall prevention through education and coaching (PROTECT): a stepped wedge type I hybrid trial of effectiveness and implementation

Sydney Local Health District0 sites5,808 target enrollmentJuly 22, 2024

Overview

Phase
N/A
Intervention
Not specified
Conditions
Falls
Sponsor
Sydney Local Health District
Enrollment
5808
Status
Not Yet Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 22, 2024
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Trial participants: Inpatient hospital wards at 4 hospital sites across one local health district. Eligible wards will be acute or subacute, medical or surgical wards.
  • Staff survey and interview participants: Staff employed by the participating hospital working in nursing, allied health, medical, administrative, or environmental services teams on a ward enrolled to participate in the intervention.
  • Patient and family member/carer survey and interview participants: Admitted inpatient or family member/carer of admitted inpatient on participating ward, deemed cognitively and medically well enough to participate in a survey or interview as per Nurse Unit Manager of the ward’s clinical judgment.

Exclusion Criteria

  • Trial participants: Emergency Departments, Intensive Care Units, Paediatric and neonatal wards, Wards currently participating in another research trial with patient falls as a listed outcome, Outpatient settings.
  • Staff survey and interview participants: Has worked on the participating ward for less than one week.
  • Patient and family member/carer survey and interview participants: Inpatient who has not spent any time on ward not participating in intervention; deemed not cognitively and/or medically well enough to participate in a survey as per the Nurse Unit Manager of the ward’s clinical judgment.

Outcomes

Primary Outcomes

Not specified

Similar Trials